omeprazole has been researched along with Hyperpigmentation in 5 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Hyperpigmentation: Excessive pigmentation of the skin, usually as a result of increased epidermal or dermal melanin pigmentation, hypermelanosis. Hyperpigmentation can be localized or generalized. The condition may arise from exposure to light, chemicals or other substances, or from a primary metabolic imbalance.
Excerpt | Relevance | Reference |
---|---|---|
"We report two cases of hydroxychloroquine-induced hyperpigmentation presenting in a 50-year-old Caucasian female (case 1) and a 78-year-old female (case 2), both receiving 400 mg per day." | 7.74 | Hydroxychloroquine-induced hyperpigmentation: the staining pattern. ( Ferringer, T; Lountzis, NI; Puri, PK; Tyler, W, 2008) |
"Omeprazole has been associated with multiple adverse effects including skin reactions but, to date, cutaneous hyperpigmentation has not been described as an adverse effect of this drug." | 7.73 | Cutaneous hyperpigmentation induced by omeprazole mimicking ashy dermatosis. ( Alcolea-Rubio, LA; Ibarra-Berrocal, IJ; Martínez-Barba, E; Martínez-Escribano, JA; Ramírez-Hernández, M, 2006) |
"We report two cases of hydroxychloroquine-induced hyperpigmentation presenting in a 50-year-old Caucasian female (case 1) and a 78-year-old female (case 2), both receiving 400 mg per day." | 3.74 | Hydroxychloroquine-induced hyperpigmentation: the staining pattern. ( Ferringer, T; Lountzis, NI; Puri, PK; Tyler, W, 2008) |
"Omeprazole has been associated with multiple adverse effects including skin reactions but, to date, cutaneous hyperpigmentation has not been described as an adverse effect of this drug." | 3.73 | Cutaneous hyperpigmentation induced by omeprazole mimicking ashy dermatosis. ( Alcolea-Rubio, LA; Ibarra-Berrocal, IJ; Martínez-Barba, E; Martínez-Escribano, JA; Ramírez-Hernández, M, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Glick, A | 1 |
Sista, V | 1 |
Johnson, C | 1 |
Burlando, M | 1 |
Russo, R | 1 |
Gallo, R | 1 |
Cozzani, E | 1 |
Parodi, A | 1 |
Puri, PK | 1 |
Lountzis, NI | 1 |
Tyler, W | 1 |
Ferringer, T | 1 |
Kim, MS | 1 |
Jung, HK | 1 |
Jung, HS | 1 |
Choi, JY | 1 |
Na, YJ | 1 |
Pyun, GW | 1 |
Ryu, JH | 1 |
Moon, IH | 1 |
Jo, MS | 1 |
Ramírez-Hernández, M | 1 |
Martínez-Escribano, JA | 1 |
Martínez-Barba, E | 1 |
Alcolea-Rubio, LA | 1 |
Ibarra-Berrocal, IJ | 1 |
5 other studies available for omeprazole and Hyperpigmentation
Article | Year |
---|---|
Oral Manifestations of Commonly Prescribed Drugs.
Topics: Albuterol; Amlodipine; Anticonvulsants; Antihypertensive Agents; Atorvastatin; Bisphosphonate-Associ | 2020 |
Ashy dermatosis-like hyperpigmentation: not always the omeprazole's fault.
Topics: Humans; Hyperpigmentation; Lichen Planus; Omeprazole | 2021 |
Hydroxychloroquine-induced hyperpigmentation: the staining pattern.
Topics: Aged; Antacids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents | 2008 |
[A Case of Cronkhite-Canada syndrome showing resolution with Helicobacter pylori eradication and omeprazole].
Topics: Anti-Ulcer Agents; Colonic Polyps; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hyp | 2006 |
Cutaneous hyperpigmentation induced by omeprazole mimicking ashy dermatosis.
Topics: Anti-Ulcer Agents; Biopsy; Diagnosis, Differential; Female; Humans; Hyperpigmentation; Middle Aged; | 2006 |